Home
 > 
Resources
 > 
Plasma Therapies
 > 
Plasma availability European program

Plasma availability European program

In collaboration with industry regulators and stakeholders, PPTA has developed a system that we believe is the best way to present the distribution of core plasma protein therapies in Europe.

Table of content
This is some text inside of a div block.
This is some text inside of a div block.
Read more

The European Distribution Data Program is a voluntary manufacturer initiative undertaken in response to drug shortage concerns, and is intended to provide a reliable, country-by-country assessment of the availability of these life-saving therapies.

PPTA’s web-based system provides aggregate, monthly distribution data for the following categories of plasma protein therapies:

‍

Albumin ≤ 5%

‍

The charts can be accessed by clicking on the link to the product category of your choice. Each chart shows a 12-month snapshot consisting of two lines: one plotting the data points for the monthly distribution volume and another to show the data points for the previous 12-month average distribution volume on a rolling basis.

‍

* No reportable data available per SOPs.

‍

Distribution Data

‍

Albumin ≤5%
August 2022

‍

Austria *
Belgium & Luxemburg *
Finland *
France *
Germany
Greece *
Italy
Norway *
The Netherlands *
Portugal *
Spain
Sweden
Switzerland *
United Kingdom
EU TOTAL

‍

‍

Albumin 20% - 25%

‍

Distribution Data

‍

Albumin 20% - 25%
August 2022

‍

‍Austria
Belgium & Luxemburg*
Finland *
France *
Germany
Greece *
Italy
Norway *
The Netherlands *
Portugal
Spain
Sweden
Switzerland *  
United Kingdom
EU TOTAL

‍

‍

Intravenous Immune Globulin (IVIG)

‍

Distribution Data

‍

Intravenous Immune Globulin (IVIG)
August 2022

‍

Austria
Belgium & Luxemburg *
Denmark *
Finland
France *
Germany
Greece *
Ireland
Italy
Norway
The Netherlands *
Portugal
Spain
Sweden
Switzerland *
United Kingdom
EU TOTAL

‍

Subcutaneous and Intra-Muscular Immune Globulin (SC/IM IG)

‍

Distribution Data

‍

Subcutaneous and Intra-Muscular
Immune Globulin (SC/IM IG)
August 2022

‍

Austria
Belgium & Luxemburg *
Denmark*
Finland
France *
Germany
Greece *
Italy
Norway
The Netherlands *
Portugal *
Spain
Sweden
Switzerland*
United Kingdom
EU TOTAL

‍

‍

Plasma-Derived Factor VIII

‍

Distribution Data

‍

Plasma-derived Factor VIII
August 2022

‍

Austria *
Belgium & Luxemburg *
Finland *
France *
Germany
Greece *
Italy
Norway *
The Netherlands *
Portugal *
Spain
Sweden*
Switzerland*
United Kingdom *
EU TOTAL

‍

‍

Plasma-Derived Factor IX

‍

Distribution Data

‍

Plasma-Derived Factor IX
August 2022

‍

Austria
Belgium & Luxemburg *
Finland *
France *
Germany
Greece *
Italy
Norway *
The Netherlands *
Portugal *
Spain
Sweden *
Switzerland *
United Kingdom *

EU TOTAL

‍

* For some countries there is no reportable data available per SOPs.